198 related articles for article (PubMed ID: 19548265)
21. Abnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema.
Gittenberger-De Groot AC; Van Den Akker NM; Bartelings MM; Webb S; Van Vugt JM; Haak MC
Dev Dyn; 2004 Jun; 230(2):378-84. PubMed ID: 15162517
[TBL] [Abstract][Full Text] [Related]
22. Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms.
Burger NB; Bekker MN; de Groot CJ; Christoffels VM; Haak MC
Prenat Diagn; 2015 Jun; 35(6):517-28. PubMed ID: 25728762
[TBL] [Abstract][Full Text] [Related]
23. Specification of arterial, venous, and lymphatic endothelial cells during embryonic development.
Kume T
Histol Histopathol; 2010 May; 25(5):637-46. PubMed ID: 20238301
[TBL] [Abstract][Full Text] [Related]
24. FOXC2 transcription factor: a novel regulator of lymphangiogenesis.
Wu X; Liu NF
Lymphology; 2011 Mar; 44(1):35-41. PubMed ID: 21667821
[TBL] [Abstract][Full Text] [Related]
25. Jugular lymphatic sacs in the first trimester of pregnancy: the prevalence and the potential value in screening for chromosomal abnormalities.
van Heesch PN; Struijk PC; Brandenburg H; Steegers EA; Wildschut HI
J Perinat Med; 2008; 36(6):518-22. PubMed ID: 18681837
[TBL] [Abstract][Full Text] [Related]
26. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
Bronshtein M; Zimmer EZ; Blazer S
Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
[TBL] [Abstract][Full Text] [Related]
27. Involvement of neurons and retinoic acid in lymphatic development: new insights in increased nuchal translucency.
Burger NB; Stuurman KE; Kok E; Konijn T; Schooneman D; Niederreither K; Coles M; Agace WW; Christoffels VM; Mebius RE; van de Pavert SA; Bekker MN
Prenat Diagn; 2014 Dec; 34(13):1312-9. PubMed ID: 25088217
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of increased fetal nuchal translucency thickness.
Chen CP
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):133-8. PubMed ID: 20708516
[TBL] [Abstract][Full Text] [Related]
29. Development of the lymphatic vascular system: a mystery unravels.
Hong YK; Shin JW; Detmar M
Dev Dyn; 2004 Nov; 231(3):462-73. PubMed ID: 15376314
[TBL] [Abstract][Full Text] [Related]
30. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.
Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM
Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996
[TBL] [Abstract][Full Text] [Related]
31. Increased NCAM expression and vascular development in trisomy 16 mouse embryos: relationship with nuchal translucency.
Bekker MN; Arkesteijn JB; van den Akker NM; Hoffman S; Webb S; van Vugt JM; Gittenberger-de Groot AC
Pediatr Res; 2005 Dec; 58(6):1222-7. PubMed ID: 16306197
[TBL] [Abstract][Full Text] [Related]
32. Dual origin of avian lymphatics.
Wilting J; Aref Y; Huang R; Tomarev SI; Schweigerer L; Christ B; Valasek P; Papoutsi M
Dev Biol; 2006 Apr; 292(1):165-73. PubMed ID: 16457798
[TBL] [Abstract][Full Text] [Related]
33. Quality of nuchal translucency measurements in multifetal pregnancies.
Zohav E; Segal O; Rabinson J; Meltcer S; Anteby EY; Orvieto R
J Matern Fetal Neonatal Med; 2006 Oct; 19(10):663-6. PubMed ID: 17118742
[TBL] [Abstract][Full Text] [Related]
34. Critical roles of VEGF-C-VEGF receptor 3 in reconnection of the collecting lymph vessels in mice.
Ikomi F; Kawai Y; Nakayama J; Ogiwara N; Sasaki K; Mizuno R; Ohhashi T
Microcirculation; 2008 Oct; 15(7):591-603. PubMed ID: 18951277
[TBL] [Abstract][Full Text] [Related]
35. Effect of maternal administration of betamethasone on peripheral arterial development in fetal rabbit lungs.
Roubliova XI; Van der Biest AM; Vaast P; Lu H; Jani JC; Lewi PJ; Verbeken EK; Tibboel D; Deprest JA
Neonatology; 2008; 93(1):64-72. PubMed ID: 17703103
[TBL] [Abstract][Full Text] [Related]
36. Increased fetal nuchal translucency as a sole clue in the prenatal diagnosis of a fetus with trisomy 13.
Ki KD; Kim SR; Lee WI
Fetal Diagn Ther; 2009; 26(1):54-6. PubMed ID: 19816033
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of vascular endothelial growth factor in cardiac structures of fetus with hydrops as compared to nonhydropic controls.
Brandenburg H; Bartelings MM; Wisse LJ; Steegers EA; Gittenberger-de Groot AC
Fetal Diagn Ther; 2006; 21(1):84-91. PubMed ID: 16354983
[TBL] [Abstract][Full Text] [Related]
38. Lymphatic vessel hypoplasia in fetuses with Turner syndrome.
von Kaisenberg CS; Nicolaides KH; Brand-Saberi B
Hum Reprod; 1999 Mar; 14(3):823-6. PubMed ID: 10221720
[TBL] [Abstract][Full Text] [Related]
39. Cardiac defects, nuchal edema and abnormal lymphatic development are not associated with morphological changes in the ductus venosus.
Burger NB; Haak MC; Kok E; de Groot CJ; Shou W; Scambler PJ; Lee Y; Cho E; Christoffels VM; Bekker MN
Early Hum Dev; 2016 Oct; 101():39-48. PubMed ID: 27405055
[TBL] [Abstract][Full Text] [Related]
40. Comparative lymphatic, ocular, and metabolic phenotypes of Foxc2 haploinsufficient and aP2-FOXC2 transgenic mice.
Noon A; Hunter RJ; Witte MH; Kriederman B; Bernas M; Rennels M; Percy D; Enerbäck S; Erickson RP
Lymphology; 2006 Jun; 39(2):84-94. PubMed ID: 16910099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]